XML 80 R69.htm IDEA: XBRL DOCUMENT v2.4.0.8
Supplemental Consolidating Data (Cash Flows) (Detail) (USD $)
In Thousands, unless otherwise specified
3 Months Ended 9 Months Ended
Sep. 28, 2014
Sep. 29, 2013
Sep. 28, 2014
Sep. 29, 2013
Segment Reporting Information [Line Items]        
Repayments of Medium-term Notes     $ (7,220) $ (27,858)
Deferred Income Taxes and Tax Credits     (12,030) 0
Cash flows from operating activities:        
Net Income 150,066 162,716 770,136 658,584
Adjustments to reconcile net income to net cash provided by operating activities:        
Depreciation     130,688 122,658
Amortization of deferred loan origination costs     70,330 63,548
Amortization Of Financing Origination Fees     6,405 6,994
Pension and Other Postretirement Benefit Expense     25,281 50,158
Contributions to pension and postretirement plans     (22,528) (197,243)
Stock compensation expense     27,862 31,030
Net change in wholesale finance receivables related to sales     (194,711) (71,869)
Provision for credit losses 21,497 14,604 57,789 39,011
Foreign currency adjustments     12,948 12,874
Other, net     11,535 (63)
Changes in current assets and liabilities:        
Accounts receivable     (40,015) (65,835)
Finance receivables-accrued interest and other     (2,077) 937
Inventories     (48,095) (19,233)
Accounts payable and accrued liabilities     191,354 142,277
Restructuring reserves     0 (24,521)
Derivative instruments     (1,813) (1,818)
Increase (Decrease) in Prepaid Expenses, Other     17,336 (72,667)
Total adjustments     196,732 166,519
Net cash provided by operating activities     966,868 825,103
Cash flows from investing activities:        
Capital expenditures     (120,316) (111,690)
Origination of finance receivables     (2,918,881) (2,617,100)
Collections of finance receivables     2,308,237 2,170,919
Payments to Acquire Marketable Securities     0 4,998
Sales and redemptions of marketable securities     41,010 17,105
Other     275 6,721
Net cash (used by) provided by investing activities     (689,675) (539,043)
Repayments of Unsecured Debt     (303,000) 0
Proceeds from Issuance of Medium-term Notes     594,431 0
Cash flows from financing activities:        
Intercompany Borrowing Activity     0 0
Proceeds from Securitization Debt     847,126 647,516
Proceeds from Other Debt       647,516
Repayments of Securitization Debt     (631,302) (650,424)
borrowings of asset backed commercial paper     57,669 69,555
Proceeds from (Repayments of) Credit Facility and Other Unsecured Debt     (315,278) 99,416
Net repayments of asset-backed commercial paper     58,717  
Repayments of asset-backed commercial paper     (58,717) (58,990)
Net change in restricted cash     2,521 (6,321)
Dividends paid     (179,860) (140,772)
Purchase of common stock for treasury     (393,459) (302,196)
Excess tax benefits from share based payments     8,873 18,444
Issuance of common stock under employee stock option plans     28,850 39,145
Borrowings of asset-backed commercial paper     57,669 69,555
Net cash used by financing activities     (349,366) (312,485)
Effect of exchange rate changes on cash and cash equivalents     (14,573) (11,758)
Net increase (decrease) in cash and cash equivalents     (86,746) (38,183)
Cash and cash equivalents:        
Cash and cash equivalents—beginning of period     1,066,612 1,068,138
Net increase (decrease) in cash and cash equivalents     (86,746) (38,183)
Cash and cash equivalents—end of period 979,866 1,029,955 979,866 1,029,955
Gains (Losses) on Extinguishment of Debt     1,145 4,947
Motorcycles And Related Products Operations [Member]
       
Segment Reporting Information [Line Items]        
Repayments of Medium-term Notes     0 0
Deferred Income Taxes and Tax Credits     (1,317)  
Cash flows from operating activities:        
Net Income 102,373 115,879 757,899 706,938
Adjustments to reconcile net income to net cash provided by operating activities:        
Depreciation     125,005 118,224
Amortization of deferred loan origination costs     0 0
Amortization Of Financing Origination Fees     59 355
Pension and Other Postretirement Benefit Expense     25,281 50,158
Contributions to pension and postretirement plans     (22,528) (197,243)
Stock compensation expense     25,770 28,886
Net change in wholesale finance receivables related to sales     0 0
Provision for credit losses 0 0 0 0
Foreign currency adjustments     12,948 12,874
Other, net     6,246 207
Changes in current assets and liabilities:        
Accounts receivable     (231,716) (302,434)
Finance receivables-accrued interest and other     0 0
Inventories     (48,095) (19,233)
Accounts payable and accrued liabilities     104,795 113,902
Restructuring reserves       (24,521)
Derivative instruments     (1,813) (1,790)
Increase (Decrease) in Prepaid Expenses, Other     15,341 (74,205)
Total adjustments     (20,706) (146,410)
Net cash provided by operating activities     737,193 560,528
Cash flows from investing activities:        
Capital expenditures     (115,596) (107,886)
Origination of finance receivables     0 0
Collections of finance receivables     0 0
Payments to Acquire Marketable Securities       4,998
Sales and redemptions of marketable securities     41,010 17,105
Other     275 6,721
Net cash (used by) provided by investing activities     (74,311) (89,058)
Repayments of Unsecured Debt     (303,000)  
Proceeds from Issuance of Medium-term Notes     0  
Cash flows from financing activities:        
Intercompany Borrowing Activity     100,000 (150,000)
Proceeds from Securitization Debt     0  
Proceeds from Other Debt       0
Repayments of Securitization Debt     0 0
borrowings of asset backed commercial paper     0 0
Proceeds from (Repayments of) Credit Facility and Other Unsecured Debt     0 0
Net repayments of asset-backed commercial paper     0  
Repayments of asset-backed commercial paper       0
Net change in restricted cash     0 0
Dividends paid     (179,860) (140,772)
Purchase of common stock for treasury     (393,459) (302,196)
Excess tax benefits from share based payments     8,873 18,444
Issuance of common stock under employee stock option plans     28,850 39,145
Net cash used by financing activities     (738,596) (535,379)
Effect of exchange rate changes on cash and cash equivalents     (13,064) (10,846)
Net increase (decrease) in cash and cash equivalents     (88,778) (74,755)
Cash and cash equivalents:        
Cash and cash equivalents—beginning of period     718,912 727,716
Net increase (decrease) in cash and cash equivalents     (88,778) (74,755)
Cash and cash equivalents—end of period 630,134 652,961 630,134 652,961
Gains (Losses) on Extinguishment of Debt     0 0
Financial Services Operations [Member]
       
Segment Reporting Information [Line Items]        
Repayments of Medium-term Notes     (7,220) (27,858)
Deferred Income Taxes and Tax Credits     (10,713)  
Cash flows from operating activities:        
Net Income 47,693 46,837 132,237 136,646
Adjustments to reconcile net income to net cash provided by operating activities:        
Depreciation     5,683 4,434
Amortization of deferred loan origination costs     70,330 63,548
Amortization Of Financing Origination Fees     6,346 6,639
Pension and Other Postretirement Benefit Expense     0 0
Contributions to pension and postretirement plans     0 0
Stock compensation expense     2,092 2,144
Net change in wholesale finance receivables related to sales     0 0
Provision for credit losses 21,497 14,604 57,789 39,011
Foreign currency adjustments     0 0
Other, net     5,289 (270)
Changes in current assets and liabilities:        
Accounts receivable     0 0
Finance receivables-accrued interest and other     (2,077) 937
Inventories     0 0
Accounts payable and accrued liabilities     275,994 264,974
Restructuring reserves       0
Derivative instruments     0 (28)
Increase (Decrease) in Prepaid Expenses, Other     1,995 1,538
Total adjustments     409,883 384,798
Net cash provided by operating activities     542,120 521,444
Cash flows from investing activities:        
Capital expenditures     (4,720) (3,804)
Origination of finance receivables     (6,417,038) (5,832,489)
Collections of finance receivables     5,613,949 5,314,439
Payments to Acquire Marketable Securities       0
Sales and redemptions of marketable securities     0 0
Other     0 0
Net cash (used by) provided by investing activities     (807,809) (521,854)
Repayments of Unsecured Debt     0  
Proceeds from Issuance of Medium-term Notes     594,431  
Cash flows from financing activities:        
Intercompany Borrowing Activity     (100,000) 150,000
Proceeds from Securitization Debt     847,126  
Proceeds from Other Debt       647,516
Repayments of Securitization Debt     (631,302) (650,424)
borrowings of asset backed commercial paper     57,669 69,555
Proceeds from (Repayments of) Credit Facility and Other Unsecured Debt     (315,278) 99,416
Net repayments of asset-backed commercial paper     58,717  
Repayments of asset-backed commercial paper       (58,990)
Net change in restricted cash     2,521 (6,321)
Dividends paid     (120,000) (185,000)
Purchase of common stock for treasury     0 0
Excess tax benefits from share based payments     0 0
Issuance of common stock under employee stock option plans     0 0
Net cash used by financing activities     269,230 37,894
Effect of exchange rate changes on cash and cash equivalents     (1,509) (912)
Net increase (decrease) in cash and cash equivalents     2,032 36,572
Cash and cash equivalents:        
Cash and cash equivalents—beginning of period     347,700 340,422
Net increase (decrease) in cash and cash equivalents     2,032 36,572
Cash and cash equivalents—end of period 349,732 376,994 349,732 376,994
Gains (Losses) on Extinguishment of Debt     1,145 4,947
Consolidation, Eliminations [Member]
       
Cash flows from investing activities:        
Proceeds from Issuance of Medium-term Notes     0  
Cash and cash equivalents:        
Gains (Losses) on Extinguishment of Debt       0
Consolidation, Eliminations [Member]
       
Segment Reporting Information [Line Items]        
Repayments of Medium-term Notes     0 0
Deferred Income Taxes and Tax Credits     0  
Cash flows from operating activities:        
Net Income 0 0 (120,000) (185,000)
Adjustments to reconcile net income to net cash provided by operating activities:        
Depreciation     0 0
Amortization of deferred loan origination costs     0   
Amortization Of Financing Origination Fees     0 0
Pension and Other Postretirement Benefit Expense     0 0
Contributions to pension and postretirement plans     0 0
Stock compensation expense     0 0
Net change in wholesale finance receivables related to sales     (194,711) (71,869)
Provision for credit losses 0 0 0 0
Foreign currency adjustments     0 0
Other, net     0 0
Changes in current assets and liabilities:        
Accounts receivable     191,701 236,599
Finance receivables-accrued interest and other     0 0
Inventories     0 0
Accounts payable and accrued liabilities     (189,435) (236,599)
Restructuring reserves       0
Derivative instruments     0 0
Increase (Decrease) in Prepaid Expenses, Other     0 0
Total adjustments     (192,445) (71,869)
Net cash provided by operating activities     (312,445) (256,869)
Cash flows from investing activities:        
Capital expenditures     0 0
Origination of finance receivables     3,498,157 3,215,389
Collections of finance receivables     (3,305,712) (3,143,520)
Payments to Acquire Marketable Securities       0
Sales and redemptions of marketable securities     0 0
Other     0 0
Net cash (used by) provided by investing activities     192,445 71,869
Repayments of Unsecured Debt     0  
Cash flows from financing activities:        
Intercompany Borrowing Activity     0 0
Proceeds from Securitization Debt     0  
Proceeds from Other Debt       0
Repayments of Securitization Debt     0 0
borrowings of asset backed commercial paper     0 0
Proceeds from (Repayments of) Credit Facility and Other Unsecured Debt     0 0
Net repayments of asset-backed commercial paper     0  
Repayments of asset-backed commercial paper       0
Net change in restricted cash     0 0
Dividends paid     120,000 185,000
Purchase of common stock for treasury     0 0
Excess tax benefits from share based payments     0 0
Issuance of common stock under employee stock option plans     0 0
Net cash used by financing activities     120,000 185,000
Effect of exchange rate changes on cash and cash equivalents     0 0
Net increase (decrease) in cash and cash equivalents     0 0
Cash and cash equivalents:        
Cash and cash equivalents—beginning of period     0 0
Net increase (decrease) in cash and cash equivalents     0 0
Cash and cash equivalents—end of period 0 0 0 0
Gains (Losses) on Extinguishment of Debt     $ 0